Kyle Bromma

719 total citations
21 papers, 438 citations indexed

About

Kyle Bromma is a scholar working on Pulmonary and Respiratory Medicine, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Kyle Bromma has authored 21 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 13 papers in Biomaterials and 12 papers in Biomedical Engineering. Recurrent topics in Kyle Bromma's work include Radiation Therapy and Dosimetry (16 papers), Nanoparticle-Based Drug Delivery (13 papers) and Nanoplatforms for cancer theranostics (9 papers). Kyle Bromma is often cited by papers focused on Radiation Therapy and Dosimetry (16 papers), Nanoparticle-Based Drug Delivery (13 papers) and Nanoplatforms for cancer theranostics (9 papers). Kyle Bromma collaborates with scholars based in Canada, United States and Slovenia. Kyle Bromma's co-authors include Devika B. Chithrani, Wayne Beckham, Celina Yang, Wonmo Sung, Jan Schuemann, Perry L. Howard, Abraham Alexander, Gaetano Zafarana, Monique van Prooijen and Caterina Di Ciano‐Oliveira and has published in prestigious journals such as Scientific Reports, Cancers and Nanomaterials.

In The Last Decade

Kyle Bromma

20 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kyle Bromma Canada 14 223 188 185 92 82 21 438
Celina Yang Canada 13 221 1.0× 132 0.7× 177 1.0× 111 1.2× 59 0.7× 20 445
Gautier Laurent France 10 178 0.8× 101 0.5× 126 0.7× 85 0.9× 37 0.5× 16 368
Sophie Pinel France 5 196 0.9× 175 0.9× 84 0.5× 67 0.7× 75 0.9× 6 379
Haizhen Jin China 9 268 1.2× 131 0.7× 156 0.8× 140 1.5× 23 0.3× 20 486
Natalie D. Cummings United States 7 348 1.6× 118 0.6× 392 2.1× 230 2.5× 25 0.3× 13 672
Para Kan United States 4 176 0.8× 82 0.4× 204 1.1× 128 1.4× 31 0.4× 6 475
Zhirong Bao China 12 246 1.1× 57 0.3× 93 0.5× 86 0.9× 38 0.5× 23 411
Rebecca Majewski United States 8 287 1.3× 145 0.8× 53 0.3× 99 1.1× 36 0.4× 8 516
Rima Chouikrat France 5 343 1.5× 281 1.5× 105 0.6× 33 0.4× 93 1.1× 5 489
Liliana Aranda‐Lara Mexico 13 133 0.6× 89 0.5× 85 0.5× 116 1.3× 32 0.4× 43 418

Countries citing papers authored by Kyle Bromma

Since Specialization
Citations

This map shows the geographic impact of Kyle Bromma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle Bromma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle Bromma more than expected).

Fields of papers citing papers by Kyle Bromma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyle Bromma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle Bromma. The network helps show where Kyle Bromma may publish in the future.

Co-authorship network of co-authors of Kyle Bromma

This figure shows the co-authorship network connecting the top 25 collaborators of Kyle Bromma. A scholar is included among the top collaborators of Kyle Bromma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyle Bromma. Kyle Bromma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bromma, Kyle, Jessica Morgan, Yuri Mackeyev, et al.. (2023). Dual enhancement in the radiosensitivity of prostate cancer through nanoparticles and chemotherapeutics. Cancer Nanotechnology. 14(1). 75–75. 14 indexed citations
2.
Bromma, Kyle, Wayne Beckham, & Devika B. Chithrani. (2023). Utilizing two-dimensional monolayer and three-dimensional spheroids to enhance radiotherapeutic potential by combining gold nanoparticles and docetaxel. Cancer Nanotechnology. 14(1). 80–80. 13 indexed citations
3.
Bromma, Kyle, Nancy Dos Santos, Abraham Alexander, et al.. (2022). Enhancing nanoparticle accumulation in two dimensional, three dimensional, and xenograft mouse cancer cell models in the presence of docetaxel. Scientific Reports. 12(1). 13508–13508. 18 indexed citations
4.
Bromma, Kyle, Perry L. Howard, Alexandre G. Brolo, et al.. (2022). Nanotechnology Driven Cancer Chemoradiation: Exploiting the Full Potential of Radiotherapy with a Unique Combination of Gold Nanoparticles and Bleomycin. Pharmaceutics. 14(2). 233–233. 7 indexed citations
5.
Bromma, Kyle, James G. Donnelly, F. G. West, et al.. (2022). Repurposing Antimalarial Pyronaridine as a DNA Repair Inhibitor to Exploit the Full Potential of Gold-Nanoparticle-Mediated Radiation Response. Pharmaceutics. 14(12). 2795–2795. 2 indexed citations
6.
Bromma, Kyle, Andrew Metcalfe, Joanna M. Karasinska, et al.. (2021). Investigation of Nano-Bio Interactions within a Pancreatic Tumor Microenvironment for the Advancement of Nanomedicine in Cancer Treatment. Current Oncology. 28(3). 1962–1979. 9 indexed citations
7.
8.
Bromma, Kyle, et al.. (2020). Elucidating the fate of nanoparticles among key cell components of the tumor microenvironment for promoting cancer nanotechnology. Cancer Nanotechnology. 11(1). 8–8. 33 indexed citations
9.
Bromma, Kyle, et al.. (2020). Modulation of the Microtubule Network for Optimization of Nanoparticle Dynamics for the Advancement of Cancer Nanomedicine. Bioengineering. 7(2). 56–56. 9 indexed citations
10.
11.
Bromma, Kyle & Devika B. Chithrani. (2020). Advances in Gold Nanoparticle-Based Combined Cancer Therapy. Nanomaterials. 10(9). 1671–1671. 73 indexed citations
12.
Belderbos, Sarah, et al.. (2020). Advances in Nanoparticles.
13.
Bromma, Kyle, Wonmo Sung, Perry L. Howard, et al.. (2019). Modulation of nanoparticle uptake, intracellular distribution, and retention with docetaxel to enhance radiotherapy. British Journal of Radiology. 93(1106). 20190742–20190742. 26 indexed citations
15.
Bromma, Kyle, et al.. (2019). Modulation of gold nanoparticle mediated radiation dose enhancement through synchronization of breast tumor cell population. British Journal of Radiology. 92(1100). 20190283–20190283. 13 indexed citations
16.
Bromma, Kyle, Jayesh A. Kulkarni, Wonmo Sung, et al.. (2019). Use of a lipid nanoparticle system as a Trojan horse in delivery of gold nanoparticles to human breast cancer cells for improved outcomes in radiation therapy. Cancer Nanotechnology. 10(1). 24 indexed citations
17.
Yang, Celina, Kyle Bromma, & Devika B. Chithrani. (2018). Peptide Mediated In Vivo Tumor Targeting of Nanoparticles through Optimization in Single and Multilayer In Vitro Cell Models. Cancers. 10(3). 84–84. 33 indexed citations
18.
Yang, Celina, Kyle Bromma, Wonmo Sung, Jan Schuemann, & Devika B. Chithrani. (2018). Determining the Radiation Enhancement Effects of Gold Nanoparticles in Cells in a Combined Treatment with Cisplatin and Radiation at Therapeutic Megavoltage Energies. Cancers. 10(5). 150–150. 38 indexed citations
19.
Yang, Celina, Kyle Bromma, Caterina Di Ciano‐Oliveira, et al.. (2018). Gold nanoparticle mediated combined cancer therapy. Cancer Nanotechnology. 9(1). 38 indexed citations
20.
Bromma, Kyle, Devika B. Chithrani, & Celina Yang. (2018). Cancer nanomedicine: gold nanoparticle mediated combined cancer therapy. 32–32. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026